- Research works
- 9 ▲ 147% vs 2013–17
- Citations
- 192 20.3 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 58% world 28%
Not ranked overall: Virovek (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Virovek (United States) publish most on?
By volume in 2022–2025: Cutaneous lymphoproliferative disorders research, Monoclonal and Polyclonal Antibodies Research and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cutaneous lymphoproliferative disorders research Dermatology 0 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 3 CAR-T cell therapy research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Virovek (United States)'s research output changed?
Output in 2018–2022 was 147% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hayward
- California State University, East Bay
- Biolog (United States)
- X-ray Instrumentation Associates (United States)
- Planet Biotechnology (United States)
- Advanced Cell Diagnostics (United States)
- Sepragen Corporation (United States)
- Kaiser Permanente Hayward Medical Center
- Abeam Technologies (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.